Biolab Research Srl, Novarese, Italy.
J Clin Gastroenterol. 2012 Oct;46 Suppl:S29-32. doi: 10.1097/MCG.0b013e31826852b7.
Lactobacilli and bifidobacteria are often associated with health-promoting effects. These live microorganisms, defined as probiotics, are commonly consumed as part of fermented foods, such as yoghurt and fermented milks, or as dietary supplements. Escherichia coli is a gram-negative, rod-shaped bacterium commonly found in the lower intestine of warm-blooded organisms. As a part of the normal gut microbiota, this microorganism colonizes the gastrointestinal tract of animals and humans within a few hours after birth. All E. coli strains can produce a wide variety of biogenic amines responsible for potentially harmful systemic intoxications. Enterohemorrhagic E. coli serotype O157:H7 is a pathotype of diarrhoeagenic strains with a large virulence plasmid pO157 able to produce 1 or more Shiga toxins.
The overall aim of this study was to determine the inhibitory effects of different strains of probiotics on E. coli serotypes, including E. coli O157:H7 (CQ9485). In particular, the antagonistic activity of 4 Bifidobacterium strains (Probiotical SpA, Italy) and 16 lactic acid bacteria, more specifically 14 Lactobacillus spp. and 2 Streptococcus spp., was assessed against selected E. coli biotypes (ATCC 8739, ATCC 10536, ATCC 35218, and ATCC 25922). The diarrhoeagenic serotype O157:H7 was also tested.
The experimental data collected demonstrated an in vitro significant inhibitory effect of 6 Lactobacillus strains, namely L. rhamnosus LR04, L. rhamnosus LR06, L. plantarum LP01, L. plantarum LP02, L. pentosus LPS01, and L. delbrueckii subsp. delbrueckii LDD01, and 2 Bifidobacterium strains, B. breve BR03 and B. breve B632. The inhibiting extent was slightly different among these strains, with L. delbrueckii subsp. delbrueckii LDD01 showing the highest activity on E. coli O157:H7.
Most of the probiotics studied are able to antagonize the growth of the 5 strains of E. coli tested, including the O157:H7 biotype, well known for their characteristic to produce a wide variety of biogenic amines considered responsible for dangerous systemic intoxications.
乳杆菌和双歧杆菌常与促进健康的作用有关。这些活的微生物被定义为益生菌,通常作为发酵食品的一部分被食用,如酸奶和发酵乳,或作为膳食补充剂。大肠杆菌是一种革兰氏阴性、杆状细菌,通常存在于温血动物的下肠道中。作为正常肠道微生物群的一部分,这种微生物在动物和人类出生后几个小时内就会在胃肠道中定植。所有大肠杆菌菌株都能产生多种生物胺,这些生物胺可能导致潜在的有害全身中毒。肠出血性大肠杆菌血清型 O157:H7 是一种腹泻性菌株的病原体,其具有能够产生 1 种或多种志贺毒素的大型毒力质粒 pO157。
本研究的总体目的是确定不同益生菌菌株对大肠杆菌血清型(包括大肠杆菌 O157:H7[CQ9485])的抑制作用。特别是,评估了 4 株双歧杆菌(Probiotical SpA,意大利)和 16 株乳酸菌,更具体地说是 14 株乳杆菌和 2 株链球菌,对选定的大肠杆菌生物型(ATCC 8739、ATCC 10536、ATCC 35218 和 ATCC 25922)的拮抗活性。还测试了腹泻性血清型 O157:H7。
收集的实验数据表明,6 株乳杆菌菌株(即鼠李糖乳杆菌 LR04、鼠李糖乳杆菌 LR06、植物乳杆菌 LP01、植物乳杆菌 LP02、戊糖片球菌 LPS01 和德氏乳杆菌亚种德氏乳杆菌 LDD01)和 2 株双歧杆菌菌株(短双歧杆菌 BR03 和短双歧杆菌 B632)对大肠杆菌的体外生长具有显著的抑制作用。这些菌株的抑制程度略有不同,其中德氏乳杆菌亚种德氏乳杆菌 LDD01对大肠杆菌 O157:H7 的活性最高。
研究中的大多数益生菌都能够拮抗所测试的 5 株大肠杆菌菌株的生长,包括 O157:H7 生物型,众所周知,它能产生多种生物胺,这些生物胺被认为是导致危险全身中毒的原因。